New developments in osteoporosis treatment.
D019386:Alendronate / Q000008:administration & dosage*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D004334:Drug Administration Schedule; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D000068296:Risedronic Acid
D000924:Anticholesteremic Agents; D010281:Parathyroid Hormone; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate